Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

Monday cybersecurity recap on evolving threats, trusted tool abuse, stealthy in-memory attacks, and shifting access patterns.

Role-Based Access Control (RBAC): Group users by their job function (like ‘developer’ or ‘finance’) and assign permissions to ...